Predictive oncology reports financial results for quarter ended march 31, 2021 and provides business update

Minneapolis, may 12, 2021 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today reported financial results for the quarter ended march 31, 2021 and provided an update on business activities.

POAI Ratings Summary

POAI Quant Ranking